A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
for Psychosis Associated With Alzheimer's Disease
Drug: KarXT
70 locations incl. Chandler
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All·Age: 55 - 90
Code: NCT06126224·Phase 3·Recruiting